Evolus Inc Receivables Turnover Ratio (EOLS), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Evolus Inc   (NASDAQ: EOLS)
 

Evolus Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Evolus Inc 's ability to collect accounts receivable sequentially worsen to 5.62, indicating more challenging environment then in the second quarter 2026, but still, it is a far cry from any concerns. Evolus Inc 's Accounts Receivable average collection period in the Sep 30 2026 quarter, has increased to 65 days, from 64 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 42 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 527, from overall ranking in the second quarter 2026 at 2308.

What is Receivable Turnover Ratio?
What is Evolus Inc Selling?


What is Receivable Turnover Ratio?





EOLS Receivables Turnover Ratio (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Receivable Change 20.7 % 34.84 % 10.04 % 14.71 % 12.98 %
Y / Y Revenue Change 13.23 % 21.3 % 7.75 % 15.64 % 12.7 %
Receivable Turnover Ratio (TTM) 5.62 5.72 5.9 5.93 5.89
EOLS's Total Ranking # 527 # 2308 # 470 # 1437 #
Accounts Receivable average collection period days 65 64 62 62 62
Seq. Receivable Change -5.38 % 23.2 % -4.53 % 8.45 % 5.71 %
Seq. Revenue Change -7.29 % 15.35 % -20.15 % 32.61 % -0.69 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 9
Healthcare Sector # 43
Overall Market # 527

Receivable Turnover Ratio Statistics
High Average Low
1.39 0.83 0.22
(Jun 30 2026)   (Mar 31 2020)






Financial Statements
Evolus Inc 's Accounts Receivable $ 61 Millions Visit EOLS's Balance sheet
Evolus Inc 's Sales TTM $ 326 Millions Visit EOLS's Income Statement
Sources of EOLS's Revenues Visit EOLS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
EOLS's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
EOLS's Growth Rates EOLS's Roa EOLS's Inventory Turnover Ratio EOLS's Dividend Comparisons
EOLS's Profitability Ratios EOLS's Roi EOLS's Asset Turnover Ratio EOLS's Dividend Growth
EOLS's Valuation Ratios EOLS's Roe EOLS's Financial Strength Ratios EOLS's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Receivable at quarter ending Sep 30 2026
Corcept Therapeutics Inc  13.44 $ 963.647  Millions$ 71.710  Millions
Chemed Corporation  12.65 $ 2,661.041  Millions$ 210.387  Millions
Caredx Inc   11.75 $ 497.396  Millions$ 42.330  Millions
Teladoc Health Inc   11.50 $ 2,468.143  Millions$ 214.604  Millions
Iqvia Holdings Inc   10.43 $ 17,311.000  Millions$ 1,659.500  Millions
Encompass Health Corporation  9.41 $ 6,338.100  Millions$ 673.625  Millions
Bausch Health Companies Inc   9.15 $ 11,113.000  Millions$ 1,215.000  Millions
Pacs Group Inc   8.88 $ 5,705.049  Millions$ 642.729  Millions
Axogen inc   8.71 $ 266.926  Millions$ 30.654  Millions
Ensign Group Inc  8.62 $ 5,674.305  Millions$ 658.477  Millions
Pediatrix Medical Group Inc   8.57 $ 1,959.124  Millions$ 228.471  Millions
Tenet Healthcare Corp  8.54 $ 22,154.000  Millions$ 2,593.250  Millions
Brightspring Health Services Inc   8.50 $ 9,479.144  Millions$ 1,114.763  Millions
Sotera Health Company  8.49 $ 1,230.250  Millions$ 144.974  Millions
Tactile Systems Technology Inc   8.23 $ 357.176  Millions$ 43.385  Millions
Penumbra Inc  8.22 $ 1,560.334  Millions$ 189.735  Millions
Inspire Medical Systems inc   8.15 $ 882.194  Millions$ 108.207  Millions
Adapthealth Corp   8.14 $ 3,152.043  Millions$ 387.280  Millions
Rhythm Pharmaceuticals Inc   8.03 $ 280.748  Millions$ 34.950  Millions
Alphatec Holdings Inc   7.91 $ 839.652  Millions$ 106.153  Millions
Exelixis Inc   7.89 $ 2,496.861  Millions$ 316.636  Millions
Henry Schein Inc   7.84 $ 13,734.000  Millions$ 1,752.000  Millions
Idexx Laboratories Inc  7.78 $ 4,663.675  Millions$ 599.701  Millions
Madrigal Pharmaceuticals Inc   7.70 $ 1,427.940  Millions$ 185.380  Millions
Pulmonx Corporation  7.56 $ 89.176  Millions$ 11.791  Millions
Merit Medical Systems Inc  7.53 $ 1,612.236  Millions$ 214.065  Millions
Cerus Corporation  7.48 $ 226.798  Millions$ 30.308  Millions
Insmed Inc  7.45 $ 1,479.040  Millions$ 198.502  Millions
Novocure Limited  7.44 $ 725.388  Millions$ 97.525  Millions
Intuitive Surgical Inc   7.44 $ 12,115.600  Millions$ 1,629.350  Millions

Date modified: 2026-11-05T06:09:11+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.